N-(2-Methoxybenzyl)-2-[(3-phenyl-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamide

ID: ALA2299053

PubChem CID: 47082783

Max Phase: Preclinical

Molecular Formula: C26H21N5O3S

Molecular Weight: 483.55

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccccc1CNC(=O)CSc1nc2ccccc2c2nc(=O)c(-c3ccccc3)nn12

Standard InChI:  InChI=1S/C26H21N5O3S/c1-34-21-14-8-5-11-18(21)15-27-22(32)16-35-26-28-20-13-7-6-12-19(20)24-29-25(33)23(30-31(24)26)17-9-3-2-4-10-17/h2-14H,15-16H2,1H3,(H,27,32)

Standard InChI Key:  MHHLSTSCBZIMKZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
    9.8363  -27.3006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8351  -28.1280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5500  -28.5409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5482  -26.8878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2636  -27.2970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2624  -28.1254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6953  -27.2990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9777  -26.8814    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4107  -26.8882    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   14.1242  -27.3024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8397  -26.8916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5532  -27.3059    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8417  -26.0666    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2687  -26.8951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6940  -28.1275    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9755  -28.5382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9721  -29.3612    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6853  -29.7797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4038  -29.3690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4090  -28.5398    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6806  -30.6048    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1160  -29.7853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9821  -27.3093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9748  -28.1350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6874  -28.5492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4039  -28.1384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4032  -27.3091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6900  -26.8986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1099  -30.6101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8213  -31.0263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5389  -30.6175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5406  -29.7882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8286  -29.3758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6885  -26.0736    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.4023  -25.6599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5  8  1  0
  6 16  1  0
 15  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 15 16  1  0
 15 20  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 18 21  2  0
 19 22  1  0
 14 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 22 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 22  1  0
 28 34  1  0
 34 35  1  0
M  END

Associated Targets(Human)

CAKI-1 (44928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHN (49357 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IGROV-1 (47897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-5 (47095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOX IMVI (44321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-539 (44845 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-549 (31254 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UO-31 (46270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A498 (42825 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hs-578T (29457 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RXF 393 (41971 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNB-75 (44215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-62 (47048 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-268 (49410 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EKVX (44102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SW-620 (52400 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-4 (49676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60(TB) (4309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-92 (41141 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SR (39847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Photobacterium leiognathi (382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 483.55Molecular Weight (Monoisotopic): 483.1365AlogP: 3.72#Rotatable Bonds: 7
Polar Surface Area: 98.48Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.85CX LogP: 4.01CX LogD: 4.01
Aromatic Rings: 5Heavy Atoms: 35QED Weighted: 0.21Np Likeness Score: -1.73

References

1. Kovalenko SI, Nosulenko IS, Voskoboynik AY, Berest GG, Antipenko LN, Antipenko AN, Katsev AM.  (2013)  Novel N-aryl(alkaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides: synthesis, cytotoxicity, anticancer activity, COMPARE analysis and docking,  22  (6): [10.1007/s00044-012-0257-x]

Source